Sleep Medicine Reviews
Volume 5, Issue 3 , Pages 185-187 , June 2001

Lessons from the blind

References 

  1. Aschoff J, Hoffman K, Pohl H, Wever R. Re-entrainment of circadian rhythms after phase-shifts of the zeitgeber. Chronobiologia. 1975;11:23–78
  2. Wever RA. New York: Springer. The Circadian System of Man: Results of Experiments Under Temporal Isolation. 1979;
  3. Boivin DB, Duffy JF, Kronauer RE, Czeisler CA. Dose-response relationships for resetting of human circadian clock by light. Nature. 1996;379:540–542
  4. Lewy AJ, Wehr TA, Goodwin FK, Newsome DA, Markey SP. Light suppresses melatonin secretion in humans. Science. 1980;210:1267–1269
  5. Sack RL, Brandes RW, Kendall AR, Lewy AJ. Entrainment of free-running circadian rhythms by melaÍtonin in blind people. N Engl J Med. 2000;343:1070–1077
  6. Tzischinsky O, Shlitner A, Lavie P. The association between the nocturnal sleep gate and nocturnal onset of urinary 6-sulfatoxymelatonin. J Biol Rhythms. 1993;8:199–209
  7. Shochat T, Luboshitzky R, Lavie P. Nocturnal melaÍtonin onset is phase locked to the primary sleep gate. Am J Physiol. 1997;273:R364–R370
  8. McArthur AJ, Lewy AJ, Sack RL. Non-24-hour sleep-wake syndrome in a sighted man: circadian rhythm studies and efficacy of melatonin treatment. Sleep. 1996;19:544–553
  9. Nakagawa H, Sack RL, Lewy AJ. Sleep propensity free-runs with the temperature, melatonin and cortisol rhythms in a totally blind person. Sleep. 1992;15:330–336
  10. Edgar DM, Dement WC, Fuller CA. Effect of SCN lesions on sleep in squirrel monkeys: evidence for opponent processes in sleep-wake regulation. J Neurosci. 1993;13:1065–1079
  11. Lavie P. Melatonin: role in gating nocturnal rise in sleep propensity. J Biol Rhythms. 1997;12:657–665
  12. Sack RL, Hughes RJ, Edgar DM, Lewy AJ. Sleep promoting effects of melatonin: at what dose, in whom, under what conditions, and by what mechanisms. Sleep. 1997;20:908–915
  13. Luboshitzky R, Wagner O, Lavi S, Herer P, Lavie P. Abnormal melatonin secretion in hypogonadal men: the effect of testosterone treatment. Clin Endocrinol (Oxf). 1997;47:463–469
  14. Luboshitzky R, Lavi S, Thuma I, Lavie P. Testosterone treatment alters melatonin concentrations in male patients with gonadotropin-releasing hormone deficiency. J Clin Endocrinol Metab. 1996;81:770–774
  15. Luboshitzky R, Shenn-Orr Z, Lavi S, Lavie P. Paper presented in the 5th European Congress of Endocrinology, Turin, Italy, June 9–13. Long-term melatonin administration alters semen quality in normal men. 2001;

PII: S1087-0792(01)90176-5

doi: 10.1053/smrv.2001.0176

Sleep Medicine Reviews
Volume 5, Issue 3 , Pages 185-187 , June 2001